ERAS

Erasca, Inc.

Biotechnology · Biotechnology

$104.46 sample

-1.19 (-1.13%) 1D

Market cap

$290.6B

Price as of

2026-10-15

Latest filing

8-K · 2026-10-09

Alerts

8

Price$104.46 +3.82% 3M daily closessample

108.0397.35

2026-07-202026-08-112026-09-022026-09-232026-10-15

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Oct 09SECForm 144 filed
Oct 01INSInsider sell: 10% owner
Sep 28SECForm 144 filed
Sep 23SECDEF 14A filed
Sep 17INSInsider sell: Director
Sep 10INSInsider sell: 10% owner
Sep 04SEC10-Q filed
Sep 01SEC8-K filed: material event

Sign up to see the real ERAS record →

Company facts

SEC EDGAR registration

Name: Erasca, Inc.
Sector: Biotechnology
Industry: Biotechnology
Smart-money score: -30sample, -100 to +100
Reporting currency: USD

Who is positioning in ERAS

sample

Insiders: 18 insider transactions over 90 days, net selling, $24.4M
Congress: 2 members traded over 90 days
Institutions · 13F: 11 funds hold $1.6B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$19.1B +14.7% y/y

Q4 2024Q3 2026

Inventory$10.7B +3.3% y/y

Q4 2024Q3 2026

Accounts receivable$8.6B +19.3% y/y

Q4 2024Q3 2026

Total debt$23.0B +11.2% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $288.1B +15.0% 3M
Sample peer B: $83.4B -1.0% 3M
Sample peer C: $290.3B +6.0% 3M
Sample peer D: $108.9B +3.0% 3M
Sample peer E: $166.5B +10.1% 3M